#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Substances Modifying the Activity of Caspases


Authors: T. Bartl;  P. Žádníková;  R. Jiříkovská;  B. Maroušková;  L. Beneš
Authors‘ workplace: Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav chemických léčiv
Published in: Čes. slov. Farm., 2008; 57, 29-34
Category: Original Articles

Overview

Caspases are enzymes which play a key role in programmed cell death – apoptosis. Dysregulation of this process results in a series of disorders in which apoptosis is involved in pathogenesis. Diseases could be divided into two groups – diseases with pathological inhibition of apoptosis (cancer, some autoimmune disorders) and diseases with pathological induction of apoptosis (neurodegenerative disorders, AIDS). The paper lists the most significant activators and inhibitors of caspases as they control apoptosis and hence they are widely studied nowadays. The effects of stobadine, theophylline and adenine derivatives on the activity of caspase 1 was investigated with the use of spectrophotometry. The compounds under study showed an inhibitory effect on the enzyme tested; in one case the inhibitory effect exceeded 80%.

Key words:
caspases – apoptosis – derivatives of stobadine, theophylline, adenine


Sources

1. Russell, S. W., Rosenau, W., Lee, J. C.: Am. J. Pathol., 1972; 69, 103–118.

2. Bózner, A., Fízel, A., Kopáčová, L. et al.: Farmakologická propedeutika, 1. vyd. Bratislava, Osveta, 1984; 277, 278.

3. https://www.zdravcentra.cz, staženo 5. 1. 2007.

4. Rosypal, S.: Úvod do molekulární biologie, 1. vyd. Blansko, Grafex, 1999; 485–488.

5. http://www.fnplzen.cz/, staženo 11. 2. 2007.

6. Steller, H.: Science, 1995; 267, 1445–1449.

7. Jacobson, M. D., Weil, M., Raff, M. C.: Cell, 1997; 88, 347–354.

8. Cohen, J. J.: Immunol. Today, 1993; 14, 126–130.

9. Trauth, B. C., Keesey, J.: Cell death. In: Trauth, B. C. Boehringer Mannheim, 1998; 34–61.

10. Rudin, C. M., Thompson, C. B.: Annu. Rev. Med., 1997; 48, 267–281.

11. Riedl, S. J., Shi, Y.: Nat. Rev. Mol. Cell Biol., 2004; 5, 897–907.

12. Li, P., Nijhawan, D., Budihardjo, I. et al.: Cell, 1997; 91, 479–489.

13. Reed, J. C.: Am. J. Pathol., 2000; 157, 1415–1431.

14. Green, D. R., Kroemer, G.: J. Clin. Invest., 2005; 115, 2610–2617.

15. Varfolomeev, E. E., Ashkenazi, A.: Cell, 2004; 116, 491–497.

16. Chinnaiyan, A. M.: Neoplasia, 1999; 1, 5–15.

17. Yan, N., Shi, Y.: Annu. Rev. Cell Dev. Biol., 2005; 21, 35–56.

18. Philchenkov, A.: J. Cell Mol. Med., 2004; 8, 432–444.

19. Ho, P. K., Hawkins, C. J.: FEBS Lett., 2005; 272, 5436–5453.

20. Yuan, J. Y., Shaham, S., Ledoux, S. et al.: Cell, 1993; 75, 641–652.

21. Twomey, C., McCarthy, J. V.: J. Cell Mol. Med., 2005; 9, 345–359.

22. Fan, T. J., Han, L. H., Cong, R. S., Liang, J.: Acta Biochim. Biophys. Sinica, 2005; 37, 719–727.

23. Wolf, B. B., Green, D. R.: J. Biol. Chem., 1999; 274, 20049–20052.

24. Degterev, A., Boyce, M., Yuan, J. Y.: Oncogene, 2003; 22, 8543–8567.

25. Shi, Y.: Mol. Cells, 2002; 9, 459–470.

26. Fuentes-Prior, P., Salvesen, G. S.: Biochem. J., 2004; 384, 201–232.

27. Lavrik, I. N., Golks, A., Krammer, P. H.: J. Clin. Invest., 2005; 115, 2665–2672.

28. http://is.muni.cz/ staženo 9. 2. 2007.

29. Jin, Z. Y., El-Deiry, W. S.: Cancer Biol. Ther., 2005; 4, 139–163.

30. Thompson, C. B.: Science, 1995; 267, 1456–1462.

31. http://ustavpatologie.upol.cz, staženo 15. 2. 2007.

32. Chwajol, B.: Urologie pro praxi, 2001; 3, 119–121.

33. http://www.sukl.cz/, staženo 14. 2. 2007.

34. Hideshima, T., Chauhan, D., Podar, K. et al.: Semin. Oncol., 2001; 28, 607–612.

35. http://www.chem-online.org/generic-pharmaceutical, staženo 19. 2. 2007.

36. Oancea, M., Mani, A., Hussein, M. A., Almasan, A.: Int. J. Hematol., 2004; 80, 224–231.

37. Ückert, S., Hedlund, P., Andersson, K. E. et al.: Eur. Urol., 2006; 50, 1194–1207.

38. Klener, P.: Sanquis, 2004; 36, 14–16.

39. http://redpoll.pharmacy.ualberta.ca, staženo 14. 2. 2007.

40. Graczyk, P. P.: Restor. Neurol. Neurosci., 1999; 14, 1–23.

41. Bonuccelli, U., Del Dotto, P.: Neurology, 2006; 67, 30–38.

42. Loher, F., Bauer, C., Landauer, N. et al.: J. Pharmacol. Exp. Ther., 2004; 308, 583–590.

43. http://merops.sanger.ac.uk, staženo 27. 2. 2007.

44. Concha, N. O., Abdel-Meguid, S. S.: Current Med. Chem., 2002; 9, 713–726.

45. Beneš, L., Pronayová, N.: Pharmazie, 1994; 49, 69–70.

46. Návody firmy Calbiochem: Calbiochem User Protocol, No. 218783.

Labels
Pharmacy Clinical pharmacology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#